
FindAir is a med-tech company founded in 2016 that specializes in smart inhaler devices and telemedicine systems for asthma and COPD therapy. Their solutions aim to improve patient safety and treatment outcomes through innovative technologies, including AI for predicting asthma exacerbations. FindAir's offerings encompass smart inhaler add-ons, integrated smart inhalers, and software for patient care and research, with a mission to digitalize respiratory care and enable fully remote healthcare.

FindAir is a med-tech company founded in 2016 that specializes in smart inhaler devices and telemedicine systems for asthma and COPD therapy. Their solutions aim to improve patient safety and treatment outcomes through innovative technologies, including AI for predicting asthma exacerbations. FindAir's offerings encompass smart inhaler add-ons, integrated smart inhalers, and software for patient care and research, with a mission to digitalize respiratory care and enable fully remote healthcare.
Founded: 2016/2017 (Kraków, Poland)
Product: CE‑marked smart inhalers, sensor attachments, mobile apps and cloud platform
Focus: Digital respiratory care for asthma and COPD (remote monitoring, adherence, inhalation technique)
Team size (reported): 16 employees
Recent funding: PLN 7 million seed (closed June 21, 2023); total funding reported ~$1.7M
Certifications: CE‑marked devices; ISO 13485 (announced March 20, 2025)
Asthma and COPD management; remote monitoring, adherence, inhalation technique improvement and telemedicine.
2016
Medtech / Digital health
PLN 7,000,000
Co‑investment from the NCBR Investment Fund (NIF)
“Led by 4growth VC with participation from NCBR Investment Fund (NIF) and other investors”